drugset

drugset / Trial / NCT03020459

Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes

NCT03020459 ↗

Completed 30 enrolled Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the morphologic and functional outcomes of internal limiting membrane peeling-reposition versus peeling in idiopathic macular holes

Timeline

Start: 2017-01-01
Primary completion: 2019-07-30
Completion: 2019-08-01

Publications

Tian T, Tan H, Zhu X, Zhang X, Zhao P. PEELED INTERNAL LIMITING MEMBRANE REPOSITION FOR IDIOPATHIC MACULAR HOLES: A Pilot Randomized Controlled Trial. Retina. 2023 Feb 1;43(2):191-199. doi: 10.1097/IAE.0000000000003645. Epub 2022 Oct 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	BRILLIANT BLUE G FREE ACID	Small molecule	0.1 ml	Intravitreal

Indications